Australian Prescriber Podcast podcast

E152 - Therapeutic Guidelines Diabetes

0:00
16:38
Rewind 15 seconds
Fast Forward 15 seconds

SGLT2 inhibitors and GLP-1 receptor agonists now have well-established cardiovascular and renal benefits. What does this mean for their role in the management of type 2 diabetes? Justin Coleman chats with endocrinologist and clinical pharmacologist, Tilenka Thynne, about this and other updates to Therapeutic Guidelines Diabetes.

More episodes from "Australian Prescriber Podcast"